Mission & Vision
We’re advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases.
Watch to learn how our proprietary precision neuromodulation treatment works.

Our Novel Platform
Introducing our novel platform for neurodegenerative disease
Our investigational medical device delivers non-invasive neuromodulation with the potential to improve outcomes in a range of neurodegenerative diseases, including Alzheimer’s disease.

Our Pipeline
Leveraging our platform across multiple neurodegenerative diseases.
Focus
CogTx-001
Alzheimer’s Disease
CogTx-002
MCI - Alzheimer’s Disease
CogTx-003
Parkinson’s Disease - Dementia
CogTx-004
Multiple Sclerosis
CogTx-005
Ischemic Stroke
Discovery
Preclinical
Early Clinical
Pivotal Clinical
In market
Latest News & Updates
Stay up to date


May 9, 2023
Neuroimmune Interactions: From Basic Mechanisms to Novel Therapeutic Directions


Apr 17, 2023
Cognito finds new medical, technology heads in BrainStorm, Philips alums

Mar 23, 2023
Neuro Startup Cognito Corrals $73M as Alzheimer’s Device Commences Key Test


Mar 22, 2023